North Crest Asset Manangement, LLC Dr Reddys Laboratories LTD Transaction History
North Crest Asset Manangement, LLC
- $3.54 Billion
- Q2 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 54,525 shares of RDY stock, worth $804,789. This represents 0.02% of its overall portfolio holdings.
Number of Shares
54,525
Previous 55,025
0.91%
Holding current value
$804,789
Previous $725,000
12.97%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding RDY
# of Institutions
262Shares Held
98.7MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$158 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$136 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$134 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$129 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$91.5 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.45B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...